Case Reports
11 April 2024
Vol. 16 No. 4 (2024)
Rubella virus vaccine-induced granulomas: a case in children with ataxia-telangiectasia
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
519
Views
406
Downloads
39
HTML
Authors
Ataxia telangiectasia (AT) is a rare autosomal recessive primary immunodeficiency disorder (PID) resulting from a mutation in the ATM gene involved in DNA repair. We describe the case of a young girl with cutaneous granulomas that developed after childhood vaccinations. Immunohistochemistry revealed granulomas induced by the rubella virus vaccine. This finding raises the question of the safety of live rubella vaccine strains in immunocompromised children.
Altmetrics
Downloads
Download data is not yet available.
Citations
Van Os NJH, Jansen AFM, van Deuren M, et al. Ataxia-telangiectasia: Immunodeficiency and survival. Clin Immunol 2017;178:45–55.
Rothblum-Oviatt C, Wright J, Lefton-Greif MA, et al. Ataxia telangiectasia: a review. Orphanet J Rare Dis 2016;11:159.
Chiam LYT, Verhagen MMM, Haraldsson A, et al. Cutaneous Granulomas in Ataxia Telangiectasia and Other Primary Immunodeficiencies: Reflection of Inappropriate Immune Regulation? Dermatology 2011;22:13–9.
Buchbinder D, Hauck F, Albert MH, et al. Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders. J Clin Immuno 2019;39:81–9.
Neven B, Pérot P, Bruneau J, et al. Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies: Table 1. Clin Infect Dis 2017;64:83–6.
Browne R, Cliffe L, Ip W, et al. A case of wild type rubella associated cutaneous granuloma in ataxia telangiectasia. Pediatr Dermatol 2022;39:619–21.
Groß M, Speckmann C, May A, et al. Rubella vaccine–induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity. J Allergy Clin Immunol 2022;149:388-399.e4.
Perelygina L, Plotkin S, Russo P, et al. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J Allergy Clin Immunol 2016;138:1436-1439.e11.
Perelygina L, Buchbinder D, Dorsey MJ, et al. Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma. J Clin Immunol 2019;3:112–7.
Baumann U, Schulte JH, Groß JP, et al. Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders – Outcome After Hematopoietic Stem Cell Transplantation. Front Immunol 2022;13:886540.
How to Cite
Rubella virus vaccine-induced granulomas: a case in children with ataxia-telangiectasia. (2024). Dermatology Reports, 16(4). https://doi.org/10.4081/dr.2024.9864
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
